Abiopharma

🔍 Carter Shawn Corey (Director)

Company: Block, Inc. (XYZ)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 207 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 28,859.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By immediate family member | shares_owned_after: 1,779.00 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 20,812.00 | Footnotes: F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 296.00 | Footnotes: F4

Footnotes:

• F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs were issued pursuant to the Issuer's Outside Director Compensation Policy, and 100% of the RSUs were vested as of the date of grant.
• F2: The shares are held of record by an immediate family member of the Reporting Person.
• F3: The shares are held of record by SC Panther, LLC, for which the Reporting Person serves as the sole member.
• F4: The shares are held of record by SC Vessel 5, LLC, for which the Reporting Person serves as the sole member.